BATE KENNETH Insider Trading

Get the latest insider transactions of BATE KENNETH. BATE KENNETH is EVP; Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and ExecVP; Head of Commercial Ops in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Epizyme, Inc. ($EPZM). Discover the current value of BATE KENNETH shares.

Address: MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE, 02139MA

BATE KENNETH is Insider in these Companies

TickerCompany NameCurrent and Previous PositionsTotal SharesCurrent Value ($)
MLNMMILLENNIUM PHARMACEUTICALS INCExecVP; Head of Commercial Ops, EVP; Chief Financial Officer00.00
GNCAGENOCEA BIOSCIENCES, INC.Director00.00
AVEOAVEO PHARMACEUTICALS, INC.Director00.00
BMRNBIOMARIN PHARMACEUTICAL INCDirector11,8751,055,806.25
CATBCATABASIS PHARMACEUTICALS INCDirector00.00
EPZMEpizyme, Inc.Director00.00
VNDAVanda Pharmaceuticals Inc.Director5,00068,250.00
SNTAMADRIGAL PHARMACEUTICALS, INC.Director00.00

Insider Trading Transactions of BATE KENNETH

DateTickerCompanyOwnerRelationship Transaction Cost ($) Shares Transaction Value ($) Total Shares
Jun 30 2020AVEOAVEO PHARMACEUTICALS, INC ...BATE KENNETHDirectorOption Exercise7.524,00030,0804,000
Jun 19 2020GNCAGENOCEA BIOSCIENCES, INC.BATE KENNETHDirectorOption Exercise2.2215,00033,30015,000
Jun 18 2020SNTAMADRIGAL PHARMACEUTICALS, ...BATE KENNETHDirectorOption Exercise111.066,000666,3606,000
Jun 12 2020CATBCATABASIS PHARMACEUTICALS ...BATE KENNETHDirectorOption Exercise6.177,50046,2757,500
Jun 02 2020EPZMEpizyme, Inc.BATE KENNETHDirectorOption Exercise17.5514,013245,92814,013
Jul 19 2019GNCAGENOCEA BIOSCIENCES, INC.BATE KENNETHDirectorOption Exercise3.665,62520,5885,625
Jul 01 2019SNTAMADRIGAL PHARMACEUTICALS, ...BATE KENNETHDirectorOption Exercise100.4510,0001,004,50010,000
Jun 13 2019AVEOAVEO PHARMACEUTICALS INCBATE KENNETHDirectorOption Exercise0.7640,00030,40040,000
Jun 07 2019EPZMEpizyme, Inc.BATE KENNETHDirectorOption Exercise13.7417,633242,27717,633
Jun 05 2019CATBCATABASIS PHARMACEUTICALS ...BATE KENNETHDirectorOption Exercise6.537,50048,9757,500
Jun 25 2018GNCAGENOCEA BIOSCIENCES, INC.BATE KENNETHDirectorOption Exercise0.9945,00044,55045,000
Jun 21 2018SNTAMADRIGAL PHARMACEUTICALS, ...BATE KENNETHDirectorOption Exercise303.7910,0003,037,90010,000
Jun 21 2018SNTAMADRIGAL PHARMACEUTICALS, ...BATE KENNETHDirectorOption Exercise303.7910,0003,037,90010,000
Jun 19 2018AVEOAVEO PHARMACEUTICALS INCBATE KENNETHDirectorOption Exercise2.2740,00090,80040,000
Jun 07 2018CATBCATABASIS PHARMACEUTICALS ...BATE KENNETHDirectorOption Exercise1.4814,00020,72014,000
May 31 2018EPZMEpizyme, Inc.BATE KENNETHDirectorOption Exercise17.0012,500212,50012,500
Jul 28 2017CATBCATABASIS PHARMACEUTICALS ...BATE KENNETHDirectorOption Exercise1.276,5008,2556,500
Jun 30 2017SNTAMADRIGAL PHARMACEUTICALS, ...BATE KENNETHDirectorOption Exercise16.4610,000164,60010,000
Jun 26 2017EPZMEpizyme, Inc.BATE KENNETHDirectorOption Exercise13.6512,500170,62512,500
Jun 23 2017AVEOAVEO PHARMACEUTICALS INCBATE KENNETHDirectorOption Exercise0.7020,00014,00020,000
Jun 23 2017AVEOAVEO PHARMACEUTICALS INCBATE KENNETHDirectorOption Exercise0.7057,85740,50057,857
Jun 19 2017VNDAVanda Pharmaceuticals Inc ...BATE KENNETHDirectorBuy0.005,00005,000
Jun 19 2017VNDAVanda Pharmaceuticals Inc ...BATE KENNETHDirectorOption Exercise13.7510,000137,50010,000
Jun 15 2017GNCAGENOCEA BIOSCIENCES, INC.BATE KENNETHDirectorOption Exercise5.3415,00080,10015,000
Oct 24 2016SNTAMADRIGAL PHARMACEUTICALS, ...BATE KENNETHDirectorOption Exercise12.0120,000240,20020,000
Aug 05 2016CATBCATABASIS PHARMACEUTICALS ...BATE KENNETHDirectorOption Exercise4.556,50029,5756,500
Jun 09 2016GNCAGENOCEA BIOSCIENCES, INC.BATE KENNETHDirectorOption Exercise4.6415,00069,60015,000
May 31 2016AVEOAVEO PHARMACEUTICALS INCBATE KENNETHDirectorOption Exercise0.9220,00018,40020,000
May 31 2016AVEOAVEO PHARMACEUTICALS INCBATE KENNETHDirectorOption Exercise0.9244,02140,49944,021
May 23 2016EPZMEpizyme, Inc.BATE KENNETHDirectorOption Exercise9.3312,500116,62512,500
Dec 21 2015VNDAVanda Pharmaceuticals Inc ...BATE KENNETHDirectorOption Exercise9.3835,000328,30035,000
Jul 10 2015EPZMEpizyme, Inc.BATE KENNETHDirectorOption Exercise22.787,333167,0467,333
Jun 30 2015CATBCATABASIS PHARMACEUTICALS ...BATE KENNETHDirectorOption Exercise12.2111,094135,45811,094
Jun 18 2015BMRNBIOMARIN PHARMACEUTICAL I ...BATE KENNETHDirectorBuy0.001,100011,875
Jun 18 2015BMRNBIOMARIN PHARMACEUTICAL I ...BATE KENNETHDirectorOption Exercise122.273,300403,4913,300
Jun 01 2015AVEOAVEO PHARMACEUTICALS INCBATE KENNETHDirectorOption Exercise2.0020,00040,00020,000
Apr 06 2015AVEOAVEO PHARMACEUTICALS INCBATE KENNETHDirectorOption Exercise1.6125,15540,50025,155
Mar 02 2015GNCAGENOCEA BIOSCIENCES, INC.BATE KENNETHDirectorOption Exercise9.085,04245,7815,042
Sep 27 2004MLNMMILLENNIUM PHARMACEUTICAL ...BATE KENNETHExecVP; Head of Comme ...Option Exercise13.36125,0001,670,000125,000
Sep 02 2004MLNMMILLENNIUM PHARMACEUTICAL ...BATE KENNETHExecVP; Head of Comme ...Option Exercise12.0971,250861,41371,250
Feb 27 2004MLNMMILLENNIUM PHARMACEUTICAL ...BATE KENNETHEVP; Chief Financial ...Option Exercise17.7771,2501,266,11371,250